COMMUNIQUÉS West-GlobeNewswire

Genmab Announces Financial Results for the First Nine Months of 2018

14/11/2018 - 17:00

November 14, 2018; Copenhagen, Denmark; Interim Report for the First Nine Months Ended September 30, 2018 Highlights USD 1,441 million in net sales of DARZALEX ® (daratumumab), resulting in royalty income of DKK 1,111 [...]

On Transactions Under Regulation No 596/2014

14/11/2018 - 15:16

Additional information available in the document attached. Information prepared by: Inga Krukle Member of the Management Board JSC Olainfarm Phone: +371 28698449 E-mail: inga.krukle@olainfarm.com Attachment [...]

On Transactions Under Regulation No 596/2014

14/11/2018 - 15:15

Additional information available in the document attached. Information prepared by: Inga Krukle Member of the Management Board JSC Olainfarm Phone: +371 28698449 E-mail: inga.krukle@olainfarm.com Attachment [...]

Webinar to Highlight Technology Underlying Precipio’s ICE COLD-PCR on November 20, 2018

14/11/2018 - 15:15

Current Status, Existing and Future Applications of COLD-PCR for Cancer and Prenatal Diagnosis to Be Presented NEW HAVEN, Conn., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: [...]

About acquisition of significant shareholding

14/11/2018 - 15:13

On November 12, 2018, JSC Olainfarm received a notification from shareholder OLFIM OÜ on increased shareholding up till 7.79% from share capital with voting rights, since the November 6, 2018. The announcement of OLFIM [...]

Change in significant shareholding

14/11/2018 - 15:11

On November 12, 2018, JSC "Olainfarm" received a notification by shareholder Irina Maligina stating that since November 6, 2018, the form of participation of I.Maligina has changed: from direct to indirect. The notice [...]

Phoenix Life Sciences Receives Import Certificate for Cannabis Diabetes Drug from the Republic of Vanuatu

14/11/2018 - 15:00

DENVER, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTCMarkets: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that it has received an [...]

Nemaura Medical to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum

14/11/2018 - 15:00

LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible continuous glucose monitor (CGM) for use by people with diabetes [...]

Diffusion Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update

14/11/2018 - 15:00

Highlights Include FDA Approval of Phase 2 On-Ambulance Clinical Trial for Treatment of Stroke and Appointment of New Chief Financial Officer CHARLOTTESVILLE, Va., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Diffusion [...]

Chiesi Salutes Neonatal Intensive Care Unit Staff in Honor of Prematurity Awareness Month®

14/11/2018 - 15:00

In partnership with March of Dimes, video featuring parents of preterm infants and NICU staff raises awareness of prematurity through first-hand accounts from the NICU CARY, N.C., Nov. 14, 2018 (GLOBE NEWSWIRE) -- In [...]

Mateon Therapeutics Reports Third Quarter 2018 Financial Results

14/11/2018 - 14:45

SOUTH SAN FRANCISCO, Calif., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications, today [...]

Virginia Premier Expands Engagement With the Inovalon One® Platform

14/11/2018 - 14:45

Leading Health Plan Expands Use of Inovalon Platform to Add Automated Clinical Data Extraction and Natural Language Processing Toolsets BOWIE, Md., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading [...]

Teladoc Health, USC Collaborate for Groundbreaking Study of Virtual Care Prescribing

14/11/2018 - 14:35

Researchers take telehealth quality initiatives to the next level by examining antibiotic prescribing influences PURCHASE, NY, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual [...]

Advanced Proteome Therapeutics Reports Positive Results and Advances Collaboration with Heidelberg Pharma

14/11/2018 - 14:30

VANCOUVER, British Columbia , Nov. 14, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8) , is pleased to announce very positive results from animal [...]

Ultragenyx Announces Intent to Submit New Drug Application to U.S. FDA for UX007 for the Treatment of Long-chain Fatty Acid Oxidation Disorders in Mid-2019

14/11/2018 - 14:30

NOVATO, Calif., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases [...]

Helomics Corp Partners with UK 100,000 Genomes Project to Drive its Artificial Intelligence-Powered Precision Oncology Platform for Ovarian Cancer

14/11/2018 - 14:30

Helomics will utilize whole genome and outcome data from the U.K. 100,000 Genomes Project to advance its artificial intelligence-based platform for ovarian cancer. PITTSBURGH and LONDON, Nov. 14, 2018 (GLOBE NEWSWIRE [...]

Veritas Announces Binding Share Purchase Agreement with Leis Industries Limited for Sale of Sechelt Organic Marijuana

14/11/2018 - 14:15

VANCOUVER, British Columbia, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) ( “ Veritas ” or the “Company”) is pleased to announce that it has entered into a binding [...]

Introducing Veradigm™ Providing Next Generation Healthcare Solutions for Today’s Healthcare Challenges

14/11/2018 - 14:01

Data-driven insight and solutions CHICAGO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Today, Allscripts (NASDAQ: MDRX) announced Veradigm as the new branding for Allscripts’ Payer & Life Sciences division. Veradigm is a [...]

Replimune Reports Financial Results for the Second Fiscal Quarter, Ended September 30, and Provides Development and Corporate Update

14/11/2018 - 14:00

U.S. Clinical Sites for Phase 1/2 Trial of RP1 in Patients with Solid Tumors on Track to Initiate by End of Year Additional Product Candidates RP2 and RP3 Continue to Advance Toward the Clinic WOBURN, Mass., Nov. 14, [...]